This inventor holds 2 USPTO granted patents. Top assignee: Taiho Pharmaceutical Company Limited. Active years: 1999-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999-2000
Title: Ken-ichi Matsuo: Innovator in Anticancer Research
Introduction
Ken-ichi Matsuo is a prominent inventor based in Saitama, Japan. He has made significant contributions to the field of anticancer research, holding a total of 2 patents. His work focuses on developing innovative solutions to combat cancer through advanced molecular techniques.
Latest Patents
Matsuo's latest patents include a double-stranded oligonucleotide and an anticancer agent containing the same. Additionally, he has developed triplex oligonucleotides targeted to p120, showcasing his commitment to advancing cancer treatment methodologies.
Career Highlights
Ken-ichi Matsuo is currently employed at Taiho Pharmaceutical Company Limited, where he continues to push the boundaries of cancer research. His work at this esteemed company has allowed him to collaborate with other leading scientists in the field.
Collaborations
Matsuo has worked alongside notable colleagues such as Yoshikazu Sugimoto and Yuji Yamada. Their combined expertise has contributed to the success of various projects aimed at improving cancer therapies.
Conclusion
Ken-ichi Matsuo's innovative work in anticancer research and his contributions to the scientific community highlight his importance as an inventor. His ongoing efforts at Taiho Pharmaceutical Company Limited continue to inspire advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile